Skip to main content

Peer Review reports

From: The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy

Original Submission
11 Mar 2022 Submitted Original manuscript
3 Apr 2022 Reviewed Reviewer Report
11 Apr 2022 Reviewed Reviewer Report
1 Jul 2022 Author responded Author comments - Andrew Lovley
Resubmission - Version 2
1 Jul 2022 Submitted Manuscript version 2
4 Jul 2022 Reviewed Reviewer Report
20 Jul 2022 Reviewed Reviewer Report
27 Dec 2022 Reviewed Reviewer Report
13 Jan 2023 Author responded Author comments - Andrew Lovley
Resubmission - Version 3
13 Jan 2023 Submitted Manuscript version 3
7 Feb 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
9 Feb 2023 Editorially accepted
17 Mar 2023 Article published 10.1186/s12883-023-03116-7

You can find further information about peer review here.

Back to article page